NO142303C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater

Info

Publication number
NO142303C
NO142303C NO744532A NO744532A NO142303C NO 142303 C NO142303 C NO 142303C NO 744532 A NO744532 A NO 744532A NO 744532 A NO744532 A NO 744532A NO 142303 C NO142303 C NO 142303C
Authority
NO
Norway
Prior art keywords
oksazol
derivatives
preparation
therapeutically effective
analogy procedure
Prior art date
Application number
NO744532A
Other languages
English (en)
Other versions
NO744532L (no
NO142303B (no
Inventor
Martin Charles Neville
John Pomfret Verge
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of NO744532L publication Critical patent/NO744532L/no
Publication of NO142303B publication Critical patent/NO142303B/no
Publication of NO142303C publication Critical patent/NO142303C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO744532A 1973-12-17 1974-12-16 Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater NO142303C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58351/73A GB1497536A (en) 1973-12-17 1973-12-17 2-acylaminooxazoles methods for their preparation and their use

Publications (3)

Publication Number Publication Date
NO744532L NO744532L (no) 1975-07-14
NO142303B NO142303B (no) 1980-04-21
NO142303C true NO142303C (no) 1980-07-30

Family

ID=10481393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744532A NO142303C (no) 1973-12-17 1974-12-16 Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater

Country Status (29)

Country Link
US (1) US4122183A (no)
JP (1) JPS5093968A (no)
AR (4) AR214714A1 (no)
AT (1) AT341521B (no)
BE (1) BE823424A (no)
BG (3) BG26530A4 (no)
CA (1) CA1060440A (no)
CH (3) CH605862A5 (no)
DD (1) DD115676A5 (no)
DE (1) DE2459380A1 (no)
DK (1) DK655074A (no)
EG (1) EG11873A (no)
ES (2) ES433018A1 (no)
FI (1) FI363374A (no)
FR (1) FR2254338B1 (no)
GB (1) GB1497536A (no)
HU (1) HU170454B (no)
IE (1) IE40308B1 (no)
IL (2) IL46250A (no)
LU (1) LU71499A1 (no)
NL (1) NL7416389A (no)
NO (1) NO142303C (no)
OA (1) OA04946A (no)
PH (1) PH13466A (no)
PL (2) PL94117B1 (no)
RO (1) RO70772A (no)
SE (1) SE420604B (no)
SU (3) SU552029A3 (no)
ZA (1) ZA748013B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150143A (en) 1973-12-17 1979-04-17 Lilly Industries Limited N-Substituted-acylamino-oxazoles as antiasthma agents
GB1497536A (en) * 1973-12-17 1978-01-12 Lilly Industries Ltd 2-acylaminooxazoles methods for their preparation and their use
GB1547564A (en) 1975-06-05 1979-06-20 Lilly Industries Ltd Acylated amino-heteroaryl compounds
GB1552125A (en) * 1975-06-07 1979-09-05 Lilly Industries Ltd 2-acylamino oxazoles
IT1099996B (it) * 1978-10-17 1985-09-28 Anic Spa Derivati del 4,5-difenil-ossazolo 2-ammino o 2-tio sostituiti e procedimento per il loro ottenimento
US4666502A (en) * 1982-02-09 1987-05-19 Sandoz Ltd. Herbicidal N-thienyl-chloroacetamides
CH655312A5 (de) * 1982-02-09 1986-04-15 Sandoz Ag Chloracetamide.
GB2127816B (en) * 1982-09-30 1986-05-08 Lilly Co Eli Herbicidal 1-heterocyclic-2-pyrrolidinone derivatives
US4500343A (en) * 1982-09-30 1985-02-19 Eli Lilly And Company Oxazolyl and thiazolyl amides as herbicides
US6228871B1 (en) 1995-07-10 2001-05-08 Merck & Co., Inc. Angiogenesis inhibitors
AU747427B2 (en) * 1998-07-10 2002-05-16 Merck & Co., Inc. Novel angiogenesis inhibitors
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
EP2634185B1 (en) 2012-03-02 2016-01-13 Sareum Limited TYK2 kinase inhibitors
JP6239118B2 (ja) * 2013-09-03 2017-11-29 サリウム リミテッド 医薬化合物
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2401522A (en) * 1942-04-17 1946-06-04 Firm Sandoz Ltd Aromatic carboxylic acid amides and a process for their manufacture
US3152136A (en) * 1958-10-30 1964-10-06 Dow Chemical Co Dinitroaroyl-nu-pyridyl amides
US3682954A (en) * 1970-02-04 1972-08-08 Upjohn Co Bis (3-pyrazolidone) compounds
DE2045049A1 (de) * 1970-09-11 1972-03-23 Dr Karl Thomae GmbH, 7950 Biberach Neue Nitrofurandenvate und Ver fahren zu ihrer Herstellung
GB1264258A (no) * 1970-10-10 1972-02-16
BE791087A (fr) * 1971-11-15 1973-03-01 Lepetit Spa Oxazoles 2,4,5-trisubstitues et leur preparation
GB1497536A (en) * 1973-12-17 1978-01-12 Lilly Industries Ltd 2-acylaminooxazoles methods for their preparation and their use

Also Published As

Publication number Publication date
AR214714A1 (es) 1979-07-31
IE40308B1 (en) 1979-04-25
JPS5093968A (no) 1975-07-26
AR209919A1 (es) 1977-06-15
HU170454B (no) 1977-06-28
GB1497536A (en) 1978-01-12
CH605931A5 (no) 1978-10-13
ES433018A1 (es) 1977-05-16
AR215640A1 (es) 1979-10-31
AR212547A1 (es) 1978-07-31
EG11873A (en) 1977-11-30
SU609466A3 (ru) 1978-05-30
BE823424A (fr) 1975-06-16
SE420604B (sv) 1981-10-19
FR2254338A1 (no) 1975-07-11
FR2254338B1 (no) 1982-02-12
SU623518A3 (ru) 1978-09-05
ATA1000074A (de) 1977-06-15
SU552029A3 (ru) 1977-03-25
ES451058A1 (es) 1977-11-16
BG26669A4 (no) 1979-05-15
CH605861A5 (no) 1978-10-13
SE7415778L (no) 1975-06-18
AT341521B (de) 1978-02-10
US4122183A (en) 1978-10-24
AU7648274A (en) 1976-06-17
IL52719A0 (en) 1977-10-31
BG25992A3 (no) 1979-01-12
PL97985B1 (pl) 1978-04-29
IE40308L (en) 1975-06-17
BG26530A4 (no) 1979-04-12
NO744532L (no) 1975-07-14
RO70772A (ro) 1981-09-24
DK655074A (no) 1975-08-25
NO142303B (no) 1980-04-21
NL7416389A (nl) 1975-06-19
CA1060440A (en) 1979-08-14
CH605862A5 (no) 1978-10-13
PL94117B1 (no) 1977-07-30
DE2459380A1 (de) 1975-06-19
IL46250A (en) 1978-09-29
DD115676A5 (no) 1975-10-12
FI363374A (no) 1975-06-18
LU71499A1 (no) 1976-11-11
OA04946A (fr) 1980-10-31
IL46250A0 (en) 1975-03-13
PH13466A (en) 1980-05-15
ZA748013B (en) 1976-08-25

Similar Documents

Publication Publication Date Title
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
NO141262C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE409994B (sv) Forfarande for framstellning av amidinokarbamider